-
14061por Des Jarlais, Don C.“…The programs in the USA also offer many additional services for drug users, including condom distribution, referrals to substance abuse treatment, HIV, hepatitis C virus (HCV), hepatitis B virus (HBV) counseling and testing, overdose education and naloxone distribution to reverse for overdose. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14062por Arriazu, Elena, Ge, Xiaodong, Leung, Tung-Ming, Magdaleno, Fernando, Lopategi, Aritz, Lu, Yongke, Kitamura, Naoto, Urtasun, Raquel, Theise, Neil, Antoine, Daniel J, Nieto, Natalia“…DESIGN AND RESULTS: Patients with long-term hepatitis C virus (HCV) progressing in disease stage displayed enhanced hepatic OPN and HMGB1 immunostaining, which correlated with fibrosis stage, whereas it remained similar in non-progressors. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14063por Steiner, Sebastian, Bucsics, Theresa, Schwabl, Philipp, Mandorfer, Mattias, Scheiner, Bernhard, Aichelburg, Maximilian Christopher, Grabmeier-Pfistershammer, Katharina, Ferenci, Peter, Trauner, Michael, Peck-Radosavljevic, Markus, Reiberger, Thomas“…AIM: We aimed to investigate the efficacy of interferon and ribavirin-free sofosbuvir/ledipasvir (SOF/LDV) and ritonavir boosted paritaprevir/ombitasvir with or without dasabuvir (2D/3D) regimens in a real-life cohort of human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfected patients. The study focused on efficacy, need for changes in antiretroviral therapy (ART) due to drug-drug interaction (DDI), and treatment-associated changes in liver stiffness. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14064por Pons, Mònica, Santos, Begoña, Simón-Talero, Macarena, Ventura-Cots, Meritxell, Riveiro-Barciela, Mar, Esteban, Rafael, Augustin, Salvador, Genescà, Joan“…BACKGROUND: We aimed to investigate the early changes in liver and spleen stiffness measurement (LSM, SSM) in hepatitis C virus (HCV) patients with compensated advanced chronic liver disease (cACLD) treated with new antivirals (DAA) to elucidate factors determining the initial change in stiffness and its implications for the long-term follow up of HCV-cured patients. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14065“…METHODS: The impact of three balancing methods and one feature selection method is explored, to assess the ability of SVMs to classify imbalanced diagnostic pathology data associated with the laboratory diagnosis of hepatitis B (HBV) and hepatitis C (HCV) infections. Random forests (RFs) for predictor variable selection, and data reshaping to overcome a large imbalance of negative to positive test results in relation to HBV and HCV immunoassay results, are examined. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14066por Raihan, Ruksana“…But the disease burden will still remain high for some time as the infected people are getting older and living longer. Hepatitis C virus (HCV) infection is a growing problem in Malaysia. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14067“…BACKGROUND: Human pegivirus-1 (HPgV-1) is a member of the Flaviviridae family whose genomic organization and mode of cellular entry is similar to that of hepatitis C virus (HCV). The E2 glycoprotein of HPgV-1 is the principle mediator in the virus-cell interaction and as such harbors most of HPgV-1’s antigenic determinants. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14068“…BACKGROUND: Direct-acting antiviral (DAA) resistance-associated substitutions (RASs) can jeopardize the effectiveness of DAAs in patients with hepatitis C virus (HCV). The selection pressure by pegylated-interferon (Peg-IFN) plus ribavirin (P/R) treatment may enhance HCV genome variation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14069“…INTRODUCTION: Ledipasvir/sofosbuvir (LDV/SOF) for hepatitis C virus (HCV) treatment provides an oral interferon-free treatment regimen with high rates of sustained virologic response (SVR). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14070por Fujii, Hideki, Umemura, Atsushi, Nishikawa, Taichiro, Yamaguchi, Kanji, Moriguchi, Michihisa, Nakamura, Hideki, Yasui, Kohichiroh, Minami, Masahito, Tanaka, Saiyu, Ishikawa, Hiroki, Kimura, Hiroyuki, Takami, Shiro, Nagao, Yasuyuki, Shima, Toshihide, Itoh, Yoshito“…AIM: To investigate daclatasvir (DCV) and asunaprevir (ASV) efficacy in hepatitis C (HCV) patients, with respect to resistance-associated substitutions (RASs). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14071por Brothers, Thomas D., Kirkland, Susan, Theou, Olga, Zona, Stefano, Malagoli, Andrea, Wallace, Lindsay M. K., Stentarelli, Chiara, Mussini, Cristina, Falutz, Julian, Guaraldi, Giovanni, Rockwood, Kenneth“…Candidate predictor variables were baseline frailty index score, demographic (age, sex), HIV-disease related (undetectable HIV viral load, current CD4+ T-cell count, nadir CD4 count, duration of HIV infection, and duration of antiretroviral therapy [ARV] exposure), and behavioral factors (smoking, injection drug use (IDU), and hepatitis C virus co-infection). RESULTS: Four-year mortality was 3.0% (n = 29). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14072por O’Bryan, Thomas, Olsen, Chris, Rahman, Syed, Okulicz, Jason, Ganesan, Anuradha, Lalani, Tahaniyat, Deiss, Robert, Agan, Brian“…Inclusion criteria was: (1) no current or past HBV or hepatitis C infection (2) HBV vaccination after positive HIV date, (3) available post-vaccination follow-up serum HBV surface antibody (HBsAb) test, (4) CD4 cell count, HIV RNA viral load (VL), and protein levels within 90 days prior to the last vaccine dose. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14073por Uemura, Haruka, Tsukada, Kunihisa, Mizushima, Daisuke, Aoki, Takahiro, Watanabe, Koji, Kinai, Ei, Teruya, Katsuji, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Sugiyama, Masaya, Mizokami, Masashi, Oka, Shinichi“…INTRODUCTION: Almost 30 years ago, about 30% of Japanese hemophiliacs became infected with HIV-1 and hepatitis C virus (HCV) after receiving contaminated blood products. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14074por Muñoz de Rueda, P., Jiménez-Ruiz, S. M., Quiles, R., Pavón-Castillero, E. J., Muñoz-Gámez, J. A., Casado, J., Gila, A., Ruiz-Extremera, A., Salmerón, J.“…Our previous data show that hepatitis C virus (HCV) genotype 1 patients expressing the HLA-DQB1 * 0301 allele have a combined response probability of 69%, while the remaining 31% do not respond, probably because the HCV immunodominant epitope (IE) against the DQB1 * 0301 allele is mutated. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14075“…Hepatitis B virus (HBV) deoxyribonucleic (DNA) polymerase chain reaction (PCR) showed > 17 million IU/ml and hepatitis C virus (HCV) Ab reactive. A right, upper quadrant sonogram showed 4.1x0.9x2.7 cm fluid collection anterior to the right liver lobe. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14076por Shrestha, Ananta, Adhikari, Anurag, Bhattarai, Manjula, Rauniyar, Ramanuj, Debes, Jose D., Boonstra, André, Lama, Thupten K., Al Mahtab, Mamun, Butt, Amna Subhan, Akbar, Sheikh Mohammad Fazle, Aryal, Nirmal, Karn, Sapana, Manandhar, Krishna Das, Gupta, Birendra Prasad“…Mean CD4 counts, HIV viral load and presence of hepatitis B surface antigen correlated with higher HEV IgM rate, while presence of hepatitis C antibody correlated with higher rate of HEV IgG in serum. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14077por Shimelis, Techalew, Tassachew, Yayheyirad, Tadewos, Agete, Hordofa, Mesfin Worku, Amsalu, Anteneh, Tadesse, Birkneh Tilahun, Tadesse, Endale“…INTRODUCTION: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are hepatotropic viruses of public health significance worldwide. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14078por Tong, Myron J., Rosinski, Alexander A., Huynh, Claiborne T., Raman, Steven S., Lu, David S.K.“…Between 1984 and 2014, 333 patients with HCC and with hepatitis B or hepatitis C virus infection were evaluated. An adjusted lead time bias interval was added to patients with HCC who presented with HCC (no surveillance), and their survival was compared to patients whose HCC was detected by surveillance. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14079por Henriques, Bianca S., Gomes, Bruno, da Costa, Samara G., Moraes, Caroline da Silva, Mesquita, Rafael D., Dillon, Viv M., Garcia, Eloi de Souza, Azambuja, Patricia, Dillon, Roderick J., Genta, Fernando A.“…This study also provides evidence for gene acquisition from microorganisms in some peptidase families in R. prolixus: (1) family M74 (murein endopeptidase), (2) family S29 (Hepatitis C virus NS3 protease), and (3) family S24 (repressor LexA). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14080por Miozzo, Suelen A S, John, Jorge A, Appel-da-Silva, Marcelo C, Dossin, Isabella A, Tovo, Cristiane V, Mattos, Angelo A“…RESULTS: Of 738 cirrhotic patients, 582 (58.2% male) were enrolled, with mean age of 53.6 ± 12 years. Hepatitis C virus infection (36.2%) and alcohol abuse (25.6%) were the main etiologies of cirrhosis. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto